Inventor · disambiguated record
Yan Chen
Also filed as: CHEN YAN · CHEN YAN-HUA
54 granted patents·28 pending applications·909 citations·filing 1994–2025
98Inventor score
Top patents by PatentIndex Score
82 records- 0198US7858739B2Inhibitors of type 2 vascular endothelial growth factor receptorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 28, 2010·84 cites·79 claims
- 0298US7449479B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Nov 11, 2008·67 cites·16 claims
- 0398US6995174B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Feb 7, 2006·194 cites·48 claims
- 0497US8324362B2Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptorsCHEN YAN·Filed 2010·Granted Dec 4, 2012·58 cites·10 claims
- 0597US7915291B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Mar 29, 2011·40 cites·21 claims
- 0697US7847062B2Pharmacokinetic modulation and compositions for modified FN3 polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 7, 2010·77 cites·15 claims
- 0796US9862758B2Inhibitors of type 2 vascular endothelial growth factor receptorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 9, 2018·20 cites·22 claims
- 0896US8609613B2Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptidesCHEN YAN·Filed 2012·Granted Dec 17, 2013·36 cites·20 claims
- 0995US9328157B2Inhibitors of type 2 vascular endothelial growth factor receptorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted May 3, 2016·26 cites·7 claims
- 1093US9527882B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK (NO 4) LTD·Filed 2015·Granted Dec 27, 2016·6 cites·18 claims
- 1193US8299094B2Hepatitis C virus inhibitorsWANG ALAN XIANGDONG·Filed 2010·Granted Oct 30, 2012·15 cites·11 claims
- 1292US8846647B2C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activityREGUEIRO-REN ALICIA·Filed 2012·Granted Sep 30, 2014·19 cites·16 claims
- 1392US8710229B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 29, 2014·10 cites·3 claims
- 1490US7772180B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Aug 10, 2010·17 cites·20 claims
- 1589US8748415B2C-28 amines of C-3 modified betulinic acid derivatives as HIV maturation inhibitorsREGUEIRO-REN ALICIA·Filed 2012·Granted Jun 10, 2014·16 cites·15 claims
- 1688US8906889B2C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Dec 9, 2014·12 cites·19 claims
- 1788US8802661B2C-28 amides of modified C-3 betulinic acid derivatives as HIV maturation inhibitorsREGUEIRO-REN ALICIA·Filed 2011·Granted Aug 12, 2014·14 cites·22 claims
- 1888US7125663B2Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancerMILLENIUM PHARMACEUTICALS INC·Filed 2002·Granted Oct 24, 2006·19 cites·22 claims
- 1988US5932248AControlled release preparations for cytotoxic or cytostatic drugsPARAGON MEDICAL LTD·Filed 1994·Granted Aug 3, 1999·96 cites·14 claims
- 2087US8062892B2Genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancerSCHLEGEL ROBERT·Filed 2010·Granted Nov 22, 2011·10 cites·18 claims
- 2186US6849608B2Macrolide antibioticsPFIZER·Filed 2003·Granted Feb 1, 2005·24 cites·6 claims
- 2285US11084845B2C-3 and C-17 modified triterpenoids as HIV-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Granted Aug 10, 2021·1 cites·8 claims
- 2385US2023398121A1Combination therapy for the treatment of cancerNOVARTIS AG·Filed 2023·Application pending·0 cites
- 2485US2023405011A1Combination therapy for the treatment of cancerNOVARTIS AG·Filed 2023·Application pending·0 cites
- 2584US11439608B2Roles of modulators of intersectin-CDC42 signaling in Alzheimer's diseaseLU QUN·Filed 2018·Granted Sep 13, 2022·2 cites·4 claims
- 2684US9227940B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 5, 2016·3 cites·2 claims
- 2783US10995131B2Libraries of modified fibronectin type III tenth domain-containing polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 4, 2021·1 cites·14 claims
- 2883US10421774B2C-3 and C-17 modified triterpenoids as HIV-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2017·Granted Sep 24, 2019·1 cites·4 claims
- 2983US9271988B2Combination therapy comprising a CDK4/6 inhibitor and a P13K inhibitor for use in the treatment of cancerKIM SUNKYU·Filed 2012·Granted Mar 1, 2016·11 cites·4 claims
- 3083US8889871B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 18, 2014·3 cites·1 claims
- 3179US10010552B2Combination therapy comprising a CDK4/6 inhibitor and a PI3K inhibitor for use in the treatment of cancerKIM SUNKYU·Filed 2016·Granted Jul 3, 2018·4 cites·9 claims
- 3278US12291922B2Integrated control type hollow curtainCHEN YAN·Filed 2022·Granted May 6, 2025·1 cites·2 claims
- 3378US2022193079A1Combination therapy for the treatment of cancerNOVARTIS AG·Filed 2021·Application pending·0 cites
- 3477US12285393B2Roles of modulators of intersectin-Cdc42 signaling in Alzheimer's diseaseLU QUN·Filed 2022·Granted Apr 29, 2025·0 cites·1 claims
- 3577US9636375B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted May 2, 2017·1 cites·1 claims
- 3677US2023295220A1C-3 and c-17 modified triterpenoids as hiv-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2022·Application pending·0 cites
- 3776US10780102B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 4 LTD·Filed 2019·Granted Sep 22, 2020·0 cites·3 claims
- 3876US2025170134A1Combination therapy for the treatment of cancerNOVARTIS AG·Filed 2025·Application pending·0 cites
- 3976US2025177402A1Combination therapy for the treatment of cancerNOVARTIS AG·Filed 2025·Application pending·0 cites
- 4075USD1027316SCat tunnel with bedNINGBO TOP TEX TECH CO LTD·Filed 2023·Granted May 14, 2024·6 cites·1 claims
- 4175US11464790B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 4 LTD·Filed 2020·Granted Oct 11, 2022·0 cites·3 claims
- 4272US11718601B2Pyridinyl substituted oxoisoindoline compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Aug 8, 2023·0 cites·39 claims
- 4372US8889854B2C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 18, 2014·1 cites·18 claims
- 4471US2021323997A1C-3 and c-17 modified triterpenoids as hiv-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2021·Application pending·0 cites
- 4569US10245275B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 4 LTD·Filed 2017·Granted Apr 2, 2019·0 cites·4 claims
- 4666US2019046533A1Combination therapy for the treatment of cancerNOVARTIS AG·Filed 2018·Application pending·0 cites
- 4765US2017056420A1Triterpenoids with hiv maturation inhibitory activityVIIV HEALTHCARE UK (NO 4) LTD·Filed 2016·Application pending·0 cites
- 4864US2016184311A1Combination Therapy for the Treatment of CancerCHEN YAN·Filed 2014·Application pending·0 cites
- 4962US9625461B2Method of detecting cancer using delta-cateninUNIV EAST CAROLINA·Filed 2015·Granted Apr 18, 2017·0 cites·15 claims
- 5062US2025177352A1Combination treatment for cancerLAEKNA LTD·Filed 2023·Application pending·0 cites
Showing the top 50 of 82 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yan Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →